Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

A Randomized, Placebo-Controlled Trial of Oral Silymarin (Milk Thistle) For Chronic Hepatitis C: Final Results of the SYNCH Multicenter Study.

Fried MW, Navarro VJ, Afdhal NH, Belle SH, Wahed AS, Hawke RL, Doo EC, Meyers CM, Reddy KR, The SYNCH Study Group. A Randomized, Placebo-Controlled Trial of Oral Silymarin (Milk Thistle) For Chronic Hepatitis C: Final Results of the SYNCH Multicenter Study. Hepatology 2011 Oct;54(Suppl S1):475A.

Public Release Type: Journal
Publication Year: 2011
DOI: https://doi.org/10.1002/hep.24666
Authors: Meyers CM, Reddy KR, The SYNCH Study Group, Belle SH, Wahed AS, Afdhal NH, Doo EC, Hawke RL, Fried MW, Navarro VJ
Studies: Silymarin Trial for Hepatitis C and NASH

Abstract

The botanical extract silymarin, commonly known as milk thistle, is a polyphenolic flavonoid with anti-oxidant, anti-inflammatory, and immunomodulatory properties in vitro and is used extensively by patients with chronic liver disease. This trial evaluated the effect of high doses of oral silymarin on disease activity in patients with chronic hepatitis C.

Home chevron_right Publications chevron_right A Randomized, Placebo-Controlled Trial of Oral Silymarin (Milk Thistle) For Chronic Hepatitis C: Final Results of the SYNCH Multicenter Study.

A Randomized, Placebo-Controlled Trial of Oral Silymarin (Milk Thistle) For Chronic Hepatitis C: Final Results of the SYNCH Multicenter Study.

Fried MW, Navarro VJ, Afdhal NH, Belle SH, Wahed AS, Hawke RL, Doo EC, Meyers CM, Reddy KR, The SYNCH Study Group. A Randomized, Placebo-Controlled Trial of Oral Silymarin (Milk Thistle) For Chronic Hepatitis C: Final Results of the SYNCH Multicenter Study. Hepatology 2011 Oct;54(Suppl S1):475A.

Abstract